This study shows that tumor-derived GM-CSF might elicit an antitumor response in cervical cancer by inhibiting the iNOS and COX-2 expression in cervical cancer cells in a GM-CSFR-independent manner. This evidence concerns the gene CSF2 and cervical carcinoma.